Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer-Reference-Cited by-同舟云学术

Dietary geranylgeraniol can limit the activity of pitavastatin as a potential treatment for drug-resistant ovarian cancer

Published:2017-07-14 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

de Wolf Elizabeth,Abdullah Marwan Ibrahim,Jones Stefanie M.,Menezes Karen,Moss Darren M.,Drijfhout Falko P.^ORCID,Hart Sarah R.,Hoskins Clare,Stronach Euan A.,Richardson Alan^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-05595-4.pdf

Reference52 articles.

1. Ledermann, J. A. & El-Khouly, F. PARP inhibitors in ovarian cancer: Clinical evidence for informed treatment decisions. Br. J. Cancer. 113(Suppl 1), S10–6 (2015).

2. Vaughan, S. et al. Rethinking ovarian cancer: recommendations for improving outcomes. Nat. Rev. Cancer. 11, 719–725 (2011).

3. Mullen, P. J., Yu, R., Longo, J., Archer, M. C. & Penn, L. Z. The interplay between cell signalling and the mevalonate pathway in cancer. Nature Reviews Cancer. 16, 718–731 (2016).

4. Clendening, J. W. et al. Dysregulation of the mevalonate pathway promotes transformation. Proc. Natl. Acad. Sci. USA 107, 15051–15056 (2010).

5. Laezza, C. et al. P53 Regulates the Mevalonate Pathway in Human Glioblastoma Multiforme. Cell. Death Dis. 6, e1909 (2015).

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of BH3 mimetics in ovarian cancer;Cancer Treatment Reviews;2024-09

2. In vivo CRISPR screening identifies geranylgeranyl diphosphate as a pancreatic cancer tumor growth dependency;Molecular Metabolism;2024-07

3. Mononuclear phagocyte morphological response to chemoattractants is dependent on geranylgeranyl pyrophosphate;American Journal of Physiology-Endocrinology and Metabolism;2024-07-01

4. Chemoresistance ofTP53mutant AML requires the mevalonate byproduct, GGPP, for regulation of ROS and induction of a mitochondria stress response;2024-06-10

5. The Potential of Mushroom Extracts to Improve Chemotherapy Efficacy in Cancer Cells: A Systematic Review;Cells;2024-03-14